14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACRS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Aclaris Therapeutics
(Updated on Apr 23, 2024)

Sell candidate since Apr 19, 2024 Loss -1.61% PDF

No changes to the price of Aclaris Therapeutics stock on the last trading day (Tuesday, 23rd Apr 2024). During the last trading day the stock fluctuated 2.88% from a day low at $1.22 to a day high of $1.25. The price has risen in 4 of the last 10 days and is up by 2.52% over the past 2 weeks.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Aclaris Therapeutics stock with a 90% probability to be traded between $1.08 and $1.46 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACRS Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aclaris Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.22 and $1.23. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -3.17%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Aclaris Therapeutics stock

Aclaris Therapeutics finds support from accumulated volume at $1.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0350 between high and low, or 2.88%. For the last week the stock has had daily average volatility of 3.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACRS) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Aclaris Therapeutics to open at $1.23, and during the day (based on 14 day Average True Range), to move between $1.16 and $1.28, which gives a possible trading interval of +/-$0.0644 (+/-5.28%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 10.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.23 (0.82%) than the support at $1.21 (0.82%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aclaris Therapeutics stock A Buy?

Aclaris Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.635 Sell Candidate Unchanged

Predicted Opening Price for Aclaris Therapeutics of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$1.23 ( 0.683%) $1.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACRS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.26 3.55 %
R2 1.25 2.46 %
R1 1.24 1.78 %
Current price: 1.22
Support S1 1.21 -0.413 %
S2 1.21 -1.09 %
S3 1.19 -2.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.26 3.28 %
R2 1.25 2.46 %
R1 1.23 0.82 %
Current price 1.22
Support S1 1.21 -0.82%
S2 1.20 -1.64%
S3 1.19 -2.46%

FAQ

What is the symbol for Aclaris Therapeutics Stock and on which exchange is it traded?
The symbol for Aclaris Therapeutics is ACRS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aclaris Therapeutics Stock?
Aclaris Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Aclaris Therapeutics Stock?
Aclaris Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aclaris Therapeutics Stock.

What's the current price of Aclaris Therapeutics Stock?
As of the end of day on the Apr 23, 2024, the price of an Aclaris Therapeutics (ACRS) share was $1.22.

What is the 52-week high and low for Aclaris Therapeutics Stock?
The 52-week high for Aclaris Therapeutics Stock is $11.12 and the 52-week low is $0.590.

What is the market capitalization of Aclaris Therapeutics Stock?
As of the Apr 23, 2024, the market capitalization of Aclaris Therapeutics is 86.529M.

When is the next earnings date for Aclaris Therapeutics?
The upcoming earnings date for Aclaris Therapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT